Stocks/QNCX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

QNCX

↓ PDF (Pro)
Quince Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$1.20
-1.63%today
MKT CAP
$21M
-3.2% · 1Y
Earnings History
-47.8%
-39.8%
-12.4%
-237.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$1.20
Low
$0.00
Analyst Mean
$0.00
High
$0.00
1 analystNone
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-0.4x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-
Debt / Equity-
Free Cash Flow$-11,183,375
Insider Ownership3.2%
Institutional Ownership13.1%
Short % of Float12.02%
Days to Cover0.2d
1 Week-2.4%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
LUCA BENATTIDirectorSale50,000$3.47$0.17M2025-12-26
THYE DIRKChief Executive OfficerOther739,885--2025-12-10
HANNAH BRENDANChief Operating OfficerConversion27,551$0.55$0.03M2025-12-05
RYAN CHARLES SPresidentStock7,548$1.20$0.01M2025-06-18
THYE DIRKChief Executive OfficerStock150,944$1.20$0.18M2025-06-18
Top Holders
HolderType% HeldValueΔ SharesAs of
Nantahala Capital Management, LLCinstitution1.64%$0.00B-13.06%2025-12-31
Adage Capital Partners GP L.L.C.institution1.38%$0.00B+100.00%2025-12-31
Vanguard Group Incinstitution1.28%$0.00B+18.18%2025-12-31
Woodline Partners LPinstitution1.19%$0.00B+100.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund0.79%$0.00B+36.84%2025-12-31
Millennium Management Llcinstitution0.73%$0.00B-14.16%2025-12-31
IEQ Capital, LLCinstitution0.60%$0.00B-0.20%2025-12-31
Almitas Capital LLCinstitution0.57%$0.00B+87.99%2025-12-31
Superstring Capital Management LP institution0.53%$0.00B+100.00%2025-12-31
Stempoint Capital LP institution0.45%$0.00B+100.00%2025-12-31
Renaissance Technologies, LLCinstitution0.33%$0.00B+14.83%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.28%$0.00B+21.80%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.15%$0.00B-0.36%2026-02-28
iShares Trust-iShares Micro-Cap ETFfund0.08%$0.00B-1.31%2026-03-31
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.05%$0.00B+0.00%2026-03-31
Bridgeway Funds, Inc.-Ultra-Small Company Market Fundfund0.04%$0.00B+0.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.04%$0.00B+0.00%2026-03-31
VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fundfund0.02%$0.00B-41.47%2025-12-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.02%$0.00B+0.00%2026-02-28
VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd.fund0.01%$0.00B-65.00%2025-12-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for QNCX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.